You're reading: Wall Street Journal: AstraZeneca’s Covid-19 vaccine is safe, 79% effective in late-stage US trials

Wall Street Journal: AstraZeneca’s Covid-19 vaccine is safe, 79% effective in late-stage US trials

Published March 23, 2021 at 3:06 am

People line up as they wait to receive the Sinopharm and AstraZeneca vaccines against the Covid-19 coronavirus at a hospital in Phnom Penh on March 22, 2021. (Photo by TANG CHHIN Sothy / AFP)

Photo by AFP

AstraZeneca PLC’s Covid-19 vaccine was shown to be safe and 79% effective in preventing symptomatic disease in widely anticipated U.S. clinical trials, providing a vote of confidence for the shot and a pathway for its authorization in the U.S.